Akkodis and Biolevate announce a strategic partnership to accelerate AI-assisted scientific, regulatory, and technical documentation in highly regulated industries. The partnership launches first in France and Belgium on Biolevate’s ELISE platform.
Biolevate raises a €30 million Series A co-led by RAISE France and Orange Ventures. The round includes MSD Global Health Innovation Fund, Station F, and existing investor EQT Ventures; the company says the funding accelerates international expansion, including the opening of a new Boston office, amid surging demand.
Orange Ventures invests in French health-tech startup Biolevate. Orange Business partners with Biolevate to expand trusted agentic AI across the life sciences. The partnership spans pharmaceutical research, clinical development, and regulatory processes.
Paris-based Biolevate raises a €6 million seed round led by EQT Ventures to support its platform for medical writers. The platform uses natural-language processing and visual document reading to help medical writers draft faster and keep up with the pace of new drugs.